Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation

No abstract is available for this paper.

• Publication year

  2019

• Venue

  International journal of hematology

• Publication date

  2019-03-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12185-019-02637-7PMID 30915718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients

  2018cited by this paper
• Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis

  2017cited by this paper
• The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data

  2017cited by this paper
• Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients

  2017cited by this paper
• Levetiracetam as a possible cause of secondary graft failure after allogenic hematopoietic stem cell transplantation.

  2015cited by this paper
• Busulfan triggers epileptic seizures under levetiracetam and valproic acid therapy

  2014cited by this paper
• Epidemiology and Clinical Features of Bloodstream Infections in Hematology Wards: One Year Experience at the Catholic Blood and Marrow Transplantation Center

  2013cited by this paper
• Adverse drug reactions induced by valproic acid.

  2013cited by this paper
• Levetiracetam for busulfan‐induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation

  2012cited by this paper
• Development and validation of a test dose strategy for once-daily i.v. busulfan: importance of fixed infusion rate dosing.

  2012cited by this paper
• Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan

  2010cited by this paper
• Simultaneous determination of levetiracetam and its acid metabolite (ucb L057) in serum/plasma by liquid chromatography tandem mass spectrometry.

  2010cited by this paper
• Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.

  2009cited by this paper
• Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

  2008cited by this paper
• Optimal Prevention of Seizures Induced by High‐Dose Busulfan

  2008cited by this paper
• Perspectives on interactions between antiepileptic drugs (AEDs) and antimicrobial agents

  2008cited by this paper
• Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation

  2007cited by this paper
• Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan

  2007cited by this paper
• Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.

  2007cited by this paper
• Lack of Pharmacokinetic Interaction of Levetiracetam on Carbamazepine, Valproic Acid, Topiramate, and Lamotrigine in Children with Epilepsy

  2007cited by this paper
• Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

  2007cited by this paper
• Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality.

  2007cited by this paper
• Pharmacokinetic interaction between valproic acid and meropenem

  2005cited by this paper
• Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity

  2005cited by this paper
• Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin

  2005cited by this paper
• Pharmacokinetic and metabolic studies of high-dose busulphan in adults

  2004cited by this paper
• Pharmacokinetics of high-dose busulfan in children

  2004cited by this paper
• Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics

  2004cited by this paper
• Lorazepam for seizure prophylaxis during high-dose busulfan administration

  2002cited by this paper
• Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes.

  2002cited by this paper
• A Mechanistic Approach to Antiepileptic Drug Interactions

  1998cited by this paper
• Electroencephalogram abnormality and high-dose busulfan in conditioning regimens for stem cell transplantation

  1998cited by this paper
• Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes.

  1997cited by this paper
• High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcoma

  1997cited by this paper
• Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients.

  1996cited by this paper
• Clobazam for seizure prophylaxis during busulfan chemotherapy.

  1995cited by this paper
• Clonazepam prophylaxis and busulfan-related myoclonic epilepsy in autografted acute leukemia patients.

  1995cited by this paper
• Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukemia.

  1994cited by this paper
• Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukemia

  1994cited by this paper
• Original article: Pretransplant conditioning with busulfan and cyclophosphamide in acute leukemia patients: Neurological and electroence phalographic prospective study

  1992cited by this paper
• Pretransplant conditioning with busulfan and cyclophosphamide in acute leukemia patients: neurological and electroencephalographic prospective study.

  1992cited by this paper
• Generalized Seizures Secondary to High-Dose Busulfan Therapy

  1992cited by this paper
• High dose busulfan and seizures.

  1991cited by this paper
• Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study.

  1990cited by this paper
• Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia.

  1989cited by this paper
• High‐dose chemotherapy with busulphan and cyclophosphamide and bone‐marrow transplantation for drug‐sensitive malignancies in adults: a preliminary report

  1989cited by this paper
• Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation.

  1989cited by this paper
• Busulphan and phenytoin.

  1989cited by this paper
• Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia [see comments]

  1989cited by this paper
• VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION

  1987cited by this paper
• Convulsions due to high-dose busulphan.

  1984cited by this paper

• [Effect of phenytoin and levetiracetam on busulfan blood concentration in children undergoing hematopoietic stem cell transplantation].

  2025cites this paper
• [Anticipation of pharmacotherapeutic problems prior to allo stem cell transplantation in patients with co-morbidities (SFGM-TC)].

  2025cites this paper
• Prospective observational study of oral clonazepam to prevent high-dose busulfan-induced seizures in adult patients

  2025cites this paper
• Impact of prophylactic echinocandin on the development of neurological complications in patients receiving busulfan‐containing conditioning regimens for stem cell transplantation: A single‐center retrospective study

  2024cites this paper
• The roles of epigenetic regulation in graft-versus-host disease.

  2024cites this paper
• Optimal regimen of levetiracetam for prevention of busulfan-induced seizure in patients undergoing hematopoietic stem cell transplantation: A review of available evidence

  2023cites this paper
• Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning

  2022cites this paper
• Decreased Systemic Busulfan Exposure After Oral Dosing With Concomitant Levetiracetam Compared With Phenytoin

  2021cites this paper
• Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation

  2021cites this paper
• Busulfan

  2019cites this paper
• [Drug-induced seizures: prevalence, risk factors, treatment and prevention].

  2019cites this paper
• The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data

  2017cites this paper